---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-009661"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2023-07-25T23:59:59+00:00"
generated_at: "2026-06-13T03:12:42.271078+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences adjourns annual meeting to Aug. 9 due to lack of quorum

## Summary
- Annual meeting reconvened July 25, 2023 and again adjourned for lack of quorum; new date Aug. 9, 2023 at 10:00 AM ET.
- Stockholders who already voted need not recast; proxies remain valid unless revoked.
- Voting deadline extended to Aug. 8, 2023 at 11:59 PM ET; company continues solicitation.
- Meeting was first commenced and adjourned on July 6, 2023 for same reason.

## SEC filing metadata
- accession: 0001654954-23-009661
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2023-07-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495423009661/0001654954-23-009661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495423009661/ndra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-009661
- JSON: https://secwatch.observer/filing/0001654954-23-009661.json
- Plain text: https://secwatch.observer/filing/0001654954-23-009661.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.